dornase alfa biosimilar (Teva Pharmaceutical)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namedornase alfa biosimilar (Teva Pharmaceutical)
Drug Alias NameTVB-017
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionDeoxyribonuclease 1 stimulants
TargetsDeoxyribonuclease 1
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A